Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Youmei Zeng"'
Publikováno v:
IEEE Access, Vol 12, Pp 29373-29384 (2024)
To acquire precise, dependable, and credible trajectory information from extensive motion image datasets, this study introduces a robust mining algorithm grounded in trajectory extraction for voluminous motion data. The algorithm leverages an enhance
Externí odkaz:
https://doaj.org/article/9f8635ab5a1a41f2ac1c59813167b205
Publikováno v:
2022 Global Reliability and Prognostics and Health Management (PHM-Yantai).
Bisphenol A (BPA) and Polystyrene (PS) microplastics have attracted much attention due to they were widely distributed in the environment, while their combined toxicity to aquatic organisms has rarely been studied. Therefore, this study explored that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::859a204a14e17d633567c54becd17913
https://doi.org/10.21203/rs.3.rs-1259089/v1
https://doi.org/10.21203/rs.3.rs-1259089/v1
Autor:
Wenqiao You, Youlin Li, Dandan He, Youmei Zeng, Jiangwei Zhu, Xiaofeng You, Kang Wang, Guangming Zhou, Guilong Peng
Publikováno v:
Environmental science and pollution research international. 29(31)
In the present study, pyrophosphate (PP) was used to activate peroxymonosulfate (PMS) for acid orange 7 (AO7) removal under neutral pH conditions. The removal rate of AO7 (20 mg/L) was 84% within the reaction time with a rate constant value of 0.0165
Autor:
Tingting Peng, Chuan-Yu Wu, Youmei Zeng, Jiayuan Huang, Yanrong Li, Chuanbin Wu, Ying Huang, Xin Pan, Zhengwen Zhan
Publikováno v:
AAPS PharmSciTech. 18:2919-2926
Glaucoma is an ocular disease featuring increased intraocular pressure (IOP) and its primary treatment strategy is to lower IOP by medication. Current ocular drug delivery in treating glaucoma is confronting a variety of challenges, such as low corne
Autor:
Jiayuan Huang, Xin Pan, Zhengwei Huang, Ying Huang, Jintian Chen, Yanrong Li, Chuanbin Wu, Youmei Zeng
Publikováno v:
Life sciences. 212
Aims Glaucoma is a chronic ophthalmic disease, which has become one of the leading causes to progressive and irreversible blindness. Current ophthalmic drug delivery to treat glaucoma is mostly eyedrop, whose rapid elimination on corneal surface can